The common pathways affected by inhibition of Toll-like protein in hepatocellular carcinoma cell lines that may play role in doxorubicin resistance

dc.contributor.authorDemir, A. B.
dc.contributor.authorYetkin, S.
dc.contributor.authorAlotaibi, H.
dc.contributor.authorAtabey, N.
dc.contributor.authorKoc, A.
dc.date.accessioned2026-04-04T13:37:48Z
dc.date.available2026-04-04T13:37:48Z
dc.date.issued2023
dc.departmentİnönü Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage93
dc.identifier.issn2211-5463
dc.identifier.startpage92
dc.identifier.urihttps://hdl.handle.net/11616/110083
dc.identifier.volume13
dc.identifier.wosWOS:001401044000263
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofFebs Open Bio
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.titleThe common pathways affected by inhibition of Toll-like protein in hepatocellular carcinoma cell lines that may play role in doxorubicin resistance
dc.typeConference Object

Dosyalar